5. Varney ML, Johansson SL, Singh RK (2005) Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res 15: 417–425. 6. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, et al. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625–4629. 7. Frei K, Piani D, Malipiero UV, Van Meir E, de Tribolet N, et al. (1992) Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148: 3140–3146. 8. Takanami I, Takeuchi K, Kodaira S (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57: 138–142. 9. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, et al. (2000) Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 49: 63–70. 10. Anton K, Glod J (2009) Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 10: 185–191. 11. Angst E, Reber HA, Hines OJ, Eibl G (2008) Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 144: 57–65. 12. Adamson R (2009) Role of macrophages in normal wound healing: an overview. J Wound Care 18: 349–351. 13. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH Macrophages in skin injury, repair (2011) Immunobiology 216: 753–762. 14. Romieu-Mourez R, Francois M, Boivin MN, Bouchentouf M, Spaner DE, et al. (2009) Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182: 7963–7973. 15. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, et al. (1999) A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. The Journal of biological chemistry 274: 24211–24219. 16. Heuertz RM, Tricomi SM, Ezekiel UR, Webster RO (1999) C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement. The Journal of biological chemistry 274: 17968–17974. 17. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, et al. (1997) Regulation of cell motility by mitogen-activated protein kinase. The Journal of cell biology 137: 481–492. 18. Shin EY, Kim SY, Kim EG (2001) c-Jun N-terminal kinase is involved in motility of endothelial cell. Experimental & molecular medicine 33: 276–283. 19. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. Journal of cell science 117: 4619–4628. 20. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230–247. 21. Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, et al. (2007) Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney international 72: 430–441. 22. Wang L, Li Y, Chen J, Gautam SC, Zhang Z, et al. (2002) Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Experimental hematology 30: 831–836. 23. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, et al. (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Journal of the National Cancer Institute 96: 1593–1603. 24. Xu F, Shi J, Yu B, Ni W, Wu X, et al. (2010) Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncology reports 23: 1561–1567. 25. Hata N, Shinojima N, Gumin J, Yong R, Marini F, et al. (2010) Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery 66: 144–156. 26. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer research 65: 3307–3318. 27. Kanehira M, Xin H, Hoshino K, Maemondo M, Mizuguchi H, et al. (2007) Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer gene therapy 14: 894–903. 28. Loebinger MR, Kyrtatos PG, Turmaine M, Price AN, Pankhurst Q, et al. (2009) Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer research 69: 8862–8867. 29. Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, et al. (2007) Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clinical cancer research : an official journal of the American Association for Cancer Research 13: 5020–5027. Macrophage-Associated Mesenchymal Stem Cells 30. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, et al. (2006) The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130: 1807–1821. 31. Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of cellular physiology 213: 341–347. 32. Fong EL, Chan CK, Goodman SB (2011) Stem cell homing in musculoskeletal injury. Biomaterials 32: 395–409. 33. Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, et al. (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer research 68: 4331–4339. 34. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557–563. 35. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958–969. 36. Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37: 1445–1453. 37. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, et al. (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5: e9252. 38. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PloS one 5: e10088. 39. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell- mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141–150. 40. Meriane M, Duhamel S, Lejeune L, Galipeau J, Annabi B (2006) Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow- derived stromal cells. Stem Cells 24: 2557–2565. 41. Fu X, Han B, Cai S, Lei Y, Sun T, et al. (2009) Migration of bone marrow- derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 17: 185–191. 42. Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, et al. (2010) Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell- derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun 398: 105–110. 43. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, et al. (2006) Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem cells 24: 23–33. 44. Hsieh HL, Wang HH, Wu WB, Chu PJ, Yang CM (2010) Transforming growth factor-beta1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-kappaB pathways. Journal of neuroinflammation 7: 88. 45. Mendes KN, Wang GK, Fuller GN, Zhang W (2010) JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. International journal of oncology 37: 143–153. 46. Chiou WF, Chen CC, Wei BL (2009) 3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways. Evidence-based complementary and alternative medicine: doi 10.1093/ecam/ nep140. 47. Wei L, Liu Y, Kaneto H, Fanburg BL (2010) JNK regulates serotonin-mediated proliferation and migration of pulmonary artery smooth muscle cells. American journal of physiology Lung cellular and molecular physiology 298: L863–869. 48. Yeh MC, Mukaro V, Hii CS, Ferrante A (2010) Regulation of neutrophil- mediated killing of Staphylococcus aureus and chemotaxis by c-jun NH2 terminal kinase. Journal of leukocyte biology 87: 925–932. 49. Novo E, Busletta C, Bonzo LV, Povero D, Paternostro C, et al. (2011) Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. Journal of hepatology 54: 964–974. 50. Yan XL, Lan Y, Wang XY, He WY, Yao HY, et al. (2011) Migration of dorsal aorta mesenchymal stem cells induced by mouse embryonic circulation. Developmental dynamics : an official publication of the American Association of Anatomists 240: 65–74. 51. Wu S, Wells A, Griffith LG, Lauffenburger DA (2011) Controlling multipotent stromal cell migration by integrating ‘‘course-graining’’ materials and ‘‘fine- tuning’’ small molecules via decision tree signal-response modeling. Biomaterials 32: 7524–7531. 52. Mishra PJ, Banerjee D (2011) Activation and differentiation of mesenchymal stem cells. Methods in molecular biology 717: 245–253. 53. Menon LG, Picinich S, Koneru R, Gao H, Lin SY, et al. (2007) Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem cells 25: 520–528. PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35036